Anecortave

DB12081ExperimentalSmall molecule

Anecortave is under investigation in clinical trial NCT00691717 (Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension).

Chemical structure of Anecortave
Formula / weight
C21H28O4 · 344.451 g/mol (avg)
Code names
AL-4940

Resolves to

Compound
UNIIR5Y8O51589CAS10184-70-0ChEMBLCHEMBL2348782ChEBI177649PubChem7074810
Clinical / RWD
ATCS01LA02
Structure
InChIKeyBCFCRXOJOFDUMZ-ONKRVSLGSA-NSMILES[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC=C1[C@@]2([H])CCC2=CC(=O)CC[C@]12C

What you can answer from here — as of March 06, 2025

48Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 20 drug categories
Sign in

Which companies are running trials of Anecortave, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In